PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Adding IV Aspirin to Cangrelor in Thrombectomy: No Signal, No Proof

cangreloraspirinintravenous antiplatelet therapymechanical thrombectomyacute ischaemic strokelarge vessel occlusiontandem occlusionpropensity-score overlap weightingETIS registryobservational cohortneurointervention Neurology / Neuropharmacology

Background Information

Is aspirin necessary with cangrelor in stroke thrombectomies?

In mechanical thrombectomy for stroke, optimizing platelet inhibition may influence outcomes and safety. There were no significant differences in 90-day outcomes between cangrelor alone and cangrelor with aspirin. The results suggest similar outcomes for cangrelor monotherapy and combination therapy; further studies are needed to confirm findings. Cangrelor alone may be as effective as with aspirin during thrombectomy, but more evidence is needed.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Milnerowicz M, Cagnazzo F, Desilles JP, Kyheng M, Labreuche J, Consoli A, Gory B, Dumas V, Caroff J, Veunac L, Clarençon F, Gentric JC, Cognard C, Rouchaud A, Soize S, Lapergue B, Marnat G, ETIS Investigators (see Appendix)

Citation: Milnerowicz M, Cagnazzo F, Desilles JP, et al. Intraoperative cangrelor during mechanical thrombectomy: is the systematic addition of aspirin needed?. European stroke journal. 2026;11(10). doi:10.1093/esj/aakag124

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.